| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 03/04/2010 | US20100055150 Method and composition for treatment of skeletal dysplasias |
| 03/04/2010 | US20100055122 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
| 03/04/2010 | US20100055121 Brachyury polypeptides and methods for use |
| 03/04/2010 | US20100055117 Allorestricted peptide-specific t cells |
| 03/04/2010 | US20100055115 Compositions and methods for stem cell delivery |
| 03/04/2010 | US20100055105 Novel Isolated And Purified Strains Of Chikungunya Virus And Polynucleotides And Polypetide Sequences, Diagnostic And Immunogenical Uses Thereof |
| 03/04/2010 | US20100055093 Pan-cell surface receptor-specific therapeutics |
| 03/04/2010 | US20100055083 Encapsulation of heat and moisture sensitive substances |
| 03/04/2010 | US20100055082 Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof |
| 03/04/2010 | US20100055081 Long-lasting absorption of flavonoids |
| 03/04/2010 | US20100055079 Method of Harvesting, Isolating, and Culturing Neural Stem Cells and Related Methods of Treating a Patient |
| 03/04/2010 | US20100055078 Methods of making a transplantable bone repair system using multipotent stem cells |
| 03/04/2010 | US20100055077 Methods for increasing and mobilizing hematopoietic stem cells |
| 03/04/2010 | US20100055076 Mesenchymal stem cell-mediated autologous dendritic cells with increased immunosuppression |
| 03/04/2010 | US20100055075 Methods of treating ischemic spastiticy |
| 03/04/2010 | US20100055073 Treatment of pervasive developmental disorders |
| 03/04/2010 | US20100051025 Attenuation of vasoactive oxygen carrier-induced vasoconstriction |
| 03/04/2010 | DE202009016205U1 Zusammensetzung zur topischen Anwendung A composition for topical application |
| 03/04/2010 | CA2735254A1 Non-photosynthetic micro-organisms enriched with organic selenium from seleno-hydroxyacid compounds, and applications thereof in the fields of nutrition, cosmetics, and pharmaceuticals |
| 03/03/2010 | EP2159277A1 Lactic ferment comprising a particular strain of lactobacillus acidophillus and use thereof |
| 03/03/2010 | EP2159230A1 Anti-TNF antibodies, compositions, methods and uses |
| 03/03/2010 | EP2158919A1 Method for reducing postprandial glucose levels with a composition of whey protein and fiber |
| 03/03/2010 | EP2158918A1 Method for reducing postprandial glucose levels with a composition of whey protein |
| 03/03/2010 | EP2158916A1 Administration unit comprising lactic acid bacteria |
| 03/03/2010 | EP2158222A1 Milk derived antigen specific antibodies, methods of preparation and uses thereof |
| 03/03/2010 | EP2157977A1 Modulation of intestinal flora of hiv patients |
| 03/03/2010 | EP1675465B1 Improved combination bacteriolytic therapy for the treatment of tumors |
| 03/03/2010 | EP1505973B1 Combinations for treating multiple myeloma |
| 03/03/2010 | EP1162998B1 Vaccine against streptococcus pneumoniae capsular polysaccharides |
| 03/03/2010 | CN101663041A Bacterial extract for respiratory disorders and proces for its preparation |
| 03/03/2010 | CN101658534A Method for extracting sheep embryo bioelement from sheep placenta by utilizing low temperature of liquid nitrogen |
| 03/03/2010 | CN101658533A Delivery of stem cells of antitumor medicament |
| 03/03/2010 | CN101658532A New application of DCIK cell culture supernatant preparation |
| 03/03/2010 | CN100592905C Pet food composition for skin photoprotection |
| 03/02/2010 | US7671250 Mammal that has acquired immunological tolerance to a foreign DNA and/or its expression product; expresses a fetal immature T lymphocyte transfected with the foreign DNA into a thymus that has been radiated to transiently suppress T lymphocytes |
| 03/02/2010 | US7671180 Heparin binding protein for use in diagnosis, prvention and treatment of cell proliferative, liver, neurodegeneartive, inflammatory and pancreatic disorders; wound healing agents |
| 03/02/2010 | US7671027 use of agonist of hypothalamic hormone, i.e. GnRH, for preparation to support luteal phase during infertility treatment of female mammals; pharmaceutical agent supports luteal phase after spontaneous ovulation or after stimulation of follicular growth triggering final follicular maturation and ovulation |
| 03/02/2010 | US7670762 Making an absorbable remodelable graft material that is hair-free and immunologically inert; e.g. pig skin treatment for tissue engineering material |
| 03/02/2010 | US7670628 Mesenchymal precursor cell |
| 03/02/2010 | US7670611 Cancer immunotherapy with semi-allogeneic cells |
| 03/02/2010 | US7670606 Method for administering a vaginal care composition |
| 03/02/2010 | US7670598 Method for limiting the growth of cancer cells using an attenuated measles virus |
| 03/02/2010 | US7670384 Bone graft composition comprising a bone material and a carrier comprising denatured demineralized bone |
| 02/28/2010 | CA2676955A1 Method for reducing postprandial blood glucose levels with a whey protein/fiber composition |
| 02/28/2010 | CA2676518A1 Whey protein pre-load |
| 02/25/2010 | WO2010022083A2 Bone augmentation utilizing muscle-derived progenitor compositions in biocompatible matrix, and treatments thereof |
| 02/25/2010 | WO2010021756A1 Methods and compositions for treatment of bone defects with placental cell populations |
| 02/25/2010 | WO2010021715A1 Treatment of stroke using isolated placental cells |
| 02/25/2010 | WO2010021714A2 Improved cell composition and methods of making the same |
| 02/25/2010 | WO2010021412A1 Therapeutic material for cerebral infarction, and method for regeneration of brain tissue |
| 02/25/2010 | WO2010021247A1 Pharmaceutical preparation, food or beverage having inhibitory activity on serotonin transporter |
| 02/25/2010 | WO2010021162A1 Cell preparation for bone tissue regeneration |
| 02/25/2010 | WO2010021117A1 Internal preparation for achieving beautiful skin containing milk serum kefir as the active ingredient |
| 02/25/2010 | WO2010020379A1 Composition for prevention and treatment of allergic and/or inflammatory diseases |
| 02/25/2010 | WO2010020254A1 Multilayered blood product |
| 02/25/2010 | WO2010020247A1 Multilayered blood product |
| 02/25/2010 | WO2010020056A1 Engineered synergistic oncolytic viral symbiosis |
| 02/25/2010 | WO2009134866A3 Cell membrane engineering |
| 02/25/2010 | WO2009126927A3 Methods of generating insulin-producing cells |
| 02/25/2010 | WO2009073616A3 Compositions comprising vascular and myocyte progenitor cells and methods of their use |
| 02/25/2010 | WO2008135975A3 Wireless communication system |
| 02/25/2010 | US20100048408 Method for study, determination or evaluation by gene expression analysis |
| 02/25/2010 | US20100047911 Compositions and methods for isolation, propagation, and differentiation of human stem cells and uses thereof |
| 02/25/2010 | US20100047896 Nucleic acid construct containing full length genome of human hepatitis C virus, recombinant full length virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis C virus particle |
| 02/25/2010 | US20100047838 Yeast genes that affect viral replication |
| 02/25/2010 | US20100047374 Composition for protecting muscle damage |
| 02/25/2010 | US20100047361 Active Principle which is capable of inducing the conversion of inactive TGFb-Latent into active TGFb |
| 02/25/2010 | US20100047360 Use Of Polyamines In The Treatment Of Psoriasis |
| 02/25/2010 | US20100047355 Magnetic resonance-detectable, ultrasound-detectable and/or radiopaque microcapsules and uses thereof |
| 02/25/2010 | US20100047351 Treatment of stroke using isolated placental cells |
| 02/25/2010 | US20100047320 Oral polymeric membrane feruloyl esterase producing bacteria formulation |
| 02/25/2010 | US20100047316 Repair of cartilage tissue using a matrix gel containing chondrocytes |
| 02/25/2010 | US20100047309 Graft collar and scaffold apparatuses for musculoskeletal tissue engineering and related methods |
| 02/25/2010 | US20100047308 Production methods of virus inactivated and cell-free body implant |
| 02/25/2010 | US20100047305 Extracellular Matrix Compositions |
| 02/25/2010 | US20100047288 Hybrid cells for treating cancer patients |
| 02/25/2010 | US20100047287 Outer membrane vesicles and uses thereof |
| 02/25/2010 | US20100047281 Variants of hepatitis b virus with resistance to anti-viral nucleoside agents and applications thereof |
| 02/25/2010 | US20100047280 Flavivirus ns1 subunit vaccine |
| 02/25/2010 | US20100047270 Use of plant cell membrane for the treatment of obesity |
| 02/25/2010 | US20100047261 Base-modified rna for increasing the expression of a protein |
| 02/25/2010 | US20100047220 Substances |
| 02/25/2010 | US20100047218 Reversible immortalization |
| 02/25/2010 | US20100047217 Differentiated anucleated cells and method for preparing the same |
| 02/25/2010 | US20100047216 Compositions of late passage mesenchymal stem cells (mscs) |
| 02/25/2010 | US20100047215 Stem cell targeting methods |
| 02/25/2010 | US20100047214 Methods and Compositions for Treatment of Bone Defects with Placental Cell Populations |
| 02/25/2010 | US20100047213 Cell composition and methods of making the same |
| 02/25/2010 | US20100047212 Use of the pedf factor to induce cell regeneration |
| 02/25/2010 | US20100047211 Method of growth of mesenchymal cells under non-adherent conditions for clinical applications |
| 02/25/2010 | US20100047210 Systems and Methods for Positioning of Needles and Other Devices Within Body Tissue |
| 02/25/2010 | US20100047208 Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor gm-csf in tumor cells and uses thereof |
| 02/25/2010 | US20100047198 Textile Scenting |
| 02/25/2010 | DE102008039126A1 Dermatological ointment, useful for treating e.g. allergy and eczema, comprises fatty acids in the form of stearic acids and oleic acids of shea butter, glucose and fructose, fatty acids of chia oil and hemp oil |
| 02/25/2010 | DE102008036060A1 Zellbasiertes Verfahren und Mittel zum Knochenaufbau Cell-based method and means for bone formation |
| 02/25/2010 | CA2734858A1 Bone augmentation utilizing muscle-derived progenitor compositions in biocompatible matrix, and treatments thereof |
| 02/25/2010 | CA2734740A1 Engineered synergistic oncolytic viral symbiosis |
| 02/25/2010 | CA2734555A1 Multilayered blood product |
| 02/25/2010 | CA2734446A1 Methods and compositions for treatment of bone defects with placental cell populations |
| 02/25/2010 | CA2734237A1 Treatment of stroke using isolated placental cells |